✨ Free AI Report
MeiraGTx Holdings plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview MeiraGTx Holdings plc
Research Preview

MeiraGTx Holdings plc: Business Overview, Financials & Competitive Analysis

MeiraGTx is a vertically integrated, clinical-stage genetic medicines company developing AAV gene therapies for ocular diseases, Parkinson's disease, and radiation-induced xerostomia using local delivery of small dose...

Analyst-debate audio for MeiraGTx Holdings plc

AskCyborg analysts argue the bull and bear cases for MeiraGTx Holdings plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
MeiraGTx Holdings plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Clinical-stage gene therapy company with validated manufacturing, strong partner validation, and multiple late-stage programs...

Read the full analyst-debate transcript →
Industry Biotechnology - Gene Therapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest MeiraGTx Holdings plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

MeiraGTx Holdings plc Overview

Pro stress-test →

MeiraGTx is a vertically integrated, clinical-stage genetic medicines company developing AAV gene therapies for ocular diseases, Parkinson's disease, and radiation-induced xerostomia using local delivery of small doses. The company addresses significant unmet needs across inherited retinal diseases, neurodegenerative conditions, and salivary gland dysfunction.

Strategic Profile

Pro stress-test →

MeiraGTx's competitive advantage lies in its end-to-end in-house manufacturing with 5 facilities globally, including two licensed for GMP viral vector production. In 2025, the company announced a strategic collaboration with Hologen including a $200 million cash upfront payment and formation of a joint venture with $230 million in committed capital.

Competitive Landscape

Pro stress-test →

MeiraGTx collaborates with Johnson & Johnson Innovative Medicine on inherited retinal disease therapies and Hologen Limited on CNS programs. The company competes in the gene therapy space against other AAV developers but differentiates through vertically integrated manufacturing and proprietary viral vector optimization technology.

Industry Context

MeiraGTx Holdings plc operates in Biotechnology - Gene Therapy.

Key facts

Founded: 2015 · Headquarters: New York, United States · Revenue: $33.3M (2024) · Market cap: ~$550M

What the analysts stress-tested

The top findings that survived the multi-agent debate for MeiraGTx Holdings plc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when MeiraGTx Holdings plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

AAV Gene TherapyGene therapy for inherited/neurodegenerative disorders→LuxturnaAAV gene therapy for inherited retinal diseases→ZolgensmaAAV gene therapy for spinal muscular atrophy→

Compare MeiraGTx Holdings plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

MeiraGTx Holdings plc operates in Biotechnology - Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Gene Therapy research →
NEW · MCP server

Ask your AI assistant about MeiraGTx Holdings plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare MeiraGTx Holdings plc and its top competitor on Cyborg Score”
“What did MeiraGTx Holdings plc do this quarter?”
“Is MeiraGTx Holdings plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does MeiraGTx Holdings plc do?+
MeiraGTx is a vertically integrated, clinical-stage genetic medicines company developing AAV gene therapies for ocular diseases, Parkinson's disease, and radiation-induced xerostomia using local delivery of small dose...
What is MeiraGTx Holdings plc's Cyborg Score?+
MeiraGTx Holdings plc has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are MeiraGTx Holdings plc's main competitors?+
Named competitors include AAV Gene Therapy, Luxturna, Zolgensma. The full competitive landscape is in the AskCyborg report.
How can I get the full MeiraGTx Holdings plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the MeiraGTx Holdings plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track MeiraGTx Holdings plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Anthropic9Dubai Electricity and Water Authority (DEWA)9Emaar Development PJSC9Gold Fields Limited9Western Digital Corporation9Advantest Corporation9Fast Retailing Co., Ltd.9JPMorgan Chase & Co.9Siemens AG9Space Exploration Technologies Corp8Arcellx, Inc.8Gentili Mosconi S.p.A.8Neurogene Inc.8Selvaag Bolig ASA8Satellogic Inc.8Klaveness Combination Carriers ASA8Unusual Machines, Inc.8Shoei Co., Ltd.